- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02092883
Evaluation of Neuroinflammation in Children With Infantile Spasms
November 3, 2017 updated by: Harry T Chugani, Wayne State University
Neuroinflammation in Children With Infantile Spasms Measured With 11C-PK11195 Positron Emission Tomography: Response to ACTH
The purpose of this study was to investigate the presence of neuroinflammation in children with infantile spasms using 11C-PK11195 positron emission tomography (PK PET) scan, and its response to ACTH treatment by repeating the PK PET scan after treatment.
Study Overview
Study Type
Interventional
Enrollment (Actual)
8
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Michigan
-
Detroit, Michigan, United States, 48201
- Children's Hospital of Michigan
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- A clinical diagnosis of 'cryptogenic IS'
- Normal MRI
- No other neurological disorder
Exclusion Criteria:
- Abnormal MRI
- No anti-inflammatory medication 48 hrs prior to PK PET scans
- Parent/guardian unable to give written consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Infantile Spasms
|
PK PET scan before and after ACTH treatment
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Neuroinflammation in cortical and/or subcortical structures
Time Frame: up to 6 weeks
|
Neuroinflammation in cortical and/or subcortical structures of the brain in patients with Infantile Spasms will be evaluated with 11-C-PK11195 PET scan at the baseline and 2 weeks after the completion of ACTH treatment (given over 4 weeks), i.e., 6 weeks after the baseline PET scan.
|
up to 6 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Ajay Kumar, Vijay N. Tiwari, Otto Muzik, Pulak K. Chakraborty, Harry T Chugani. In-Vivo Measurement of Brain Inflammation with [11C]-[R]-PK-11195 Positron Emission Tomography in Children with Epileptic Disorders. Epilepsy Currents 2014;14:330 (abs)
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2013
Primary Completion (Actual)
July 1, 2016
Study Completion (Actual)
July 1, 2017
Study Registration Dates
First Submitted
March 14, 2014
First Submitted That Met QC Criteria
March 18, 2014
First Posted (Estimate)
March 20, 2014
Study Record Updates
Last Update Posted (Actual)
November 7, 2017
Last Update Submitted That Met QC Criteria
November 3, 2017
Last Verified
November 1, 2017
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 25QNC
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infantile Spasms
-
University of Colorado, DenverMallinckrodtRecruitingInfantile Spasms, Non-IntractableUnited States
-
Assistance Publique - Hôpitaux de ParisOSO-AIRecruiting
-
Bio-Pharm Solutions Co., Ltd.TerminatedRefractory Infantile SpasmsUnited States, Korea, Republic of
-
UCB Biopharma S.P.R.L.TerminatedInfantile Spasms (IS)France
-
Radius Pharmaceuticals, Inc.TerminatedInfantile SpasmUnited States
-
Children's Hospital of Orange CountyRecruiting
-
CerecinActive, not recruiting
-
University of Colorado, DenverPediatric Epilepsy Research Foundation; West Therapuetics, IncSuspended
-
Suvasini SharmaUnknownInfantile SpasmIndia
-
Jazz PharmaceuticalsCompletedInfantile SpasmsUnited States, Poland
Clinical Trials on ACTH
-
Rennes University HospitalUnknown
-
All India Institute of Medical Sciences, New DelhiRecruiting
-
Phoenix Neurological Associates, LTDUnknown
-
All India Institute of Medical Sciences, New DelhiActive, not recruitingWest Syndrome | ACTH | Infantile Spasm | Ketogenic DietIndia
-
Mayo ClinicMallinckrodtCompletedProteinuria | Progressive IgA NephropathyUnited States
-
University of WuerzburgCompletedAdrenal Insufficiency | Hashimoto DiseaseGermany
-
University of MinnesotaMallinckrodtTerminatedPrimary Progressive Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Progressive Relapsing Multiple SclerosisUnited States
-
Fiechtner, Justus J., M.D., P.C.CompletedLupus Erythematosus Systemic ExacerbationUnited States
-
University of Maryland, BaltimoreMallinckrodtCompleted
-
Mayo ClinicMallinckrodtCompletedIdiopathic Membranous NephropathyUnited States, Canada